Lv0
0 积分 2024-06-29 加入
Efficacy of multi-cycle Efgartigimod in achieving minimal symptom expression in myasthenia gravis: A comparative multi-center study
15小时前
待确认
Safety and outcomes with efgartigimod use for acetylcholine receptor‐positive generalized myasthenia gravis in clinical practice
2个月前
已完结
Increased serum interleukin-41 correlates with disease severity in myasthenia gravis
3个月前
已完结
Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study
10个月前
已完结
A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis
10个月前
已完结
Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study
10个月前
已完结
皖公网安备34019202002308
